BioTech Digital Health Events 
Digital Health
SEPTEMBER 19, 2018
In the last month I have spoken at an event about digital therapeutics and been invited to speak at 5 more unrelated events on the same topic (note: I am not doing them all). In my world view, this constitutes a trend, particularly since I haven’t been asked to speak on this topic repeatedly before. […].
Digital Health Global
JANUARY 24, 2024
Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
OCTOBER 11, 2023
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.
Lloyd Price
JUNE 14, 2018
2018 Digital Health Prediction 2: Voice technology will be the first step to personalising pharma. By the end of the year we will see the use of Virtual Assistants by patients to help interact with their health data and "transact" via voice technology to order repeat prescriptions, pain management and medication requests.
Health Populi
MARCH 11, 2021
Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups. A major motivation to get to VBID is that out-of-pocket costs are rising for patient-consumers, and these hit lower-income people harder than mid-to-higher income folks.
Digital Health Global
APRIL 25, 2024
This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., These adverse events often lead to hospitalizations and treatment interruptions that can reduce treatment efficacy. The study, led by principal investigator Nitin Ohri, M.D.,
Digital Health Global
OCTOBER 13, 2023
Bilateral partnerships of this nature not only bolster our members’ businesses on the international stage, but also spotlight the robust offerings of our local ecosystem to enterprises from other growing biotech regions such as Florida,” commented Benoit Larose, CEO of BIOQuébec. Preferential registration rates for all partnered events.
Expert insights. Personalized for you.
391 
Let's personalize your content